Andrea Paul
General Counsel, LogicBio Therapeutics, Inc.
Companies
- Zentalis Pharmaceuticals, Inc.General counsel Aug 1, 2022 to Feb 5, 20251
- LogicBio Therapeutics, Inc.General counsel May 19, 2021 to Mar 3, 20222
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Zentalis Pharmaceuticals, Inc. ZNTL1,070,784 shares3$2.5M at $2.29Feb 3, 2025
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 3, 2025Sold 13,230 shares at $1.71 of Zentalis Pharmaceuticals, Inc.3
- Feb 3, 2025Granted 934,041 shares of Zentalis Pharmaceuticals, Inc.3
- Feb 2, 2024Sold 3,310 shares at $11.54 of Zentalis Pharmaceuticals, Inc.4
- Feb 1, 2024Granted 112,500 shares of Zentalis Pharmaceuticals, Inc.4
- Feb 1, 2023Granted 40,783 shares of Zentalis Pharmaceuticals, Inc.5
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Feb 5, 2024
- 5SEC EDGARForm 4 filed Feb 1, 2023